THE MODERATING EFFECTS OF DEPRESSION ON BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Rathbun, A. M. [1 ]
Harrold, L. R. [2 ]
Reed, G. W. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Med, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Orthoped, Worcester, MA 01605 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.3422
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0112
引用
收藏
页码：631 / 631
页数：1
相关论文
共 50 条
  • [31] Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers
    Hiromi Shimada
    Tomohiro Kameda
    Kenji Kanenishi
    Nobuyuki Miyatake
    Shusaku Nakashima
    Risa Wakiya
    Mikiya Kato
    Taichi Miyagi
    Mai Mahmoud Fahmy Mansour
    Toshiyuki Hata
    Norimitsu Kadowaki
    Hiroaki Dobashi
    Clinical Rheumatology, 2019, 38 : 1453 - 1458
  • [32] RACIAL DISPARITIES IN UTILIZATION OF BIOLOGIC AND DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN A CALIFORNIA MEDICAID POPULATION WITH RHEUMATOID ARTHRITIS
    Nichol, M. B.
    Wu, J.
    Harker, J. O.
    Knight, T. K.
    Wong, A. L.
    VALUE IN HEALTH, 2011, 14 (03) : A132 - A132
  • [33] Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis
    Sendaydiego, Xavier
    Gold, Laura S.
    Dubreuil, Maureen
    Andrews, James S.
    Reid, Pankti
    Liew, David F. L.
    Goulabchand, Radjiv
    Hughes, Grant C.
    Sparks, Jeffrey A.
    Jarvik, Jeffrey G.
    Singh, Siddharth
    Liew, Jean W.
    Singh, Namrata
    RHEUMATOLOGY, 2025,
  • [34] GLUCOCORTICOID SPARING EFFECT OF THE BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS IN TUNISIAN REAL LIFE PRACTICE
    Fakhfakh, R.
    Zeglaoui, H.
    El Amri, N.
    Hamila, S.
    Amara, N.
    Baccouche, K.
    Bouajina, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1439 - 1439
  • [35] Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
    Das, Priyam
    Weisenfeld, Dana
    Dahal, Kumar
    De, Debsurya
    Feathers, Vivi
    Coblyn, Jonathan S.
    Weinblatt, Michael E.
    Shadick, Nancy A.
    Cai, Tianxi
    Liao, Katherine P.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [36] Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
    Priyam Das
    Dana Weisenfeld
    Kumar Dahal
    Debsurya De
    Vivi Feathers
    Jonathan S. Coblyn
    Michael E. Weinblatt
    Nancy A. Shadick
    Tianxi Cai
    Katherine P. Liao
    Arthritis Research & Therapy, 25
  • [37] Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    Fries, JF
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 86 - 89
  • [38] Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada
    Roussy, Jean-Pascal
    Bessette, Louis
    Bernatsky, Sasha
    Rahme, Elham
    Legare, Jean
    Lachaine, Jean
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S855 - S855
  • [39] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS IN QUEBEC, CANADA
    Roussy, J. P.
    Bessette, L.
    Bernatsky, S.
    Rahme, E.
    Legare, J.
    Lachaine, J.
    VALUE IN HEALTH, 2011, 14 (07) : A316 - A316
  • [40] Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Agarwal, S.
    Zaman, T.
    Handa, R.
    SINGAPORE MEDICAL JOURNAL, 2009, 50 (07) : 686 - 692
12345